drugset / Trial / NCT00933569

Dermacyd Silver Floral (Lactic Acid) - Acceptability.

NCT00933569

Phase 3 Completed 31 enrolled Sanofi
Non-randomizedSingle-groupOpen-labelPrevention

Summary

Primary Objective: To prove the safety of the gynaecological formulation in normal conditions of use.

Timeline

Start
2009-06
Primary completion
2009-07
Completion
2009-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Lactic Acid Other / unclassified

Indications

No indication recorded.